Last reviewed · How we verify
Vernal Keratitis
Approved treatments
- Intal · Pfizer
- Cromoglicate · LEO Pharma
- Alomide · Novartis
- Cromoglycate · Vishwajit Nimgaonkar, MD PhD
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Vernal Keratitis patent landscape — cliff calendar, originator estates, attackable patents
- Vernal Keratitis treatment landscape brief
- Vernal Keratitis treatment updates RSS
Frequently asked questions about Vernal Keratitis
What drugs treat Vernal Keratitis?
Tracked treatments include Intal, Cromoglicate, Alomide, Cromoglycate.
What is the treatment for Vernal Keratitis?
Standard treatment for Vernal Keratitis includes Intal, Cromoglicate, Alomide, Cromoglycate. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Vernal Keratitis patent cliff · Vernal Keratitis CI report
- Treatment: Intal · Pfizer
- Treatment: Cromoglicate · LEO Pharma
- Treatment: Alomide · Novartis
- Treatment: Cromoglycate · Vishwajit Nimgaonkar, MD PhD
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing